| Literature DB >> 32961898 |
Maria Oczkowicz1, Tomasz Szmatoła1,2, Małgorzata Świątkiewicz3, Anna Koseniuk1, Grzegorz Smołucha1, Wojciech Witarski1, Alicja Wierzbicka1.
Abstract
Animal fats are considered to be unhealthy, in contrast to vegetable fats, which are rich in unsaturated fatty acids. However, the use of some fats, such as coconut oil, is still controversial. In our experiment, we divided experimental animals (domestic pigs) into three groups differing only in the type of fat used in the diet: group R: rapeseed oil (n = 5); group B: beef tallow (n = 5); group C: coconut oil (n = 6). After transcriptomic analysis of liver samples, we identified 188, 93, and 53 DEGs (differentially expressed genes) in R vs. B, R vs. C, and B vs. C comparisons, respectively. Next, we performed a functional analysis of identified DEGs with String and IPA software. We observed the enrichment of genes engaged in the unfolded protein response (UPR) and the acute phase response among genes upregulated in B compared to R. In contrast, cholesterol biosynthesis and cholesterol efflux enrichments were observed among genes downregulated in B when compared to R. Moreover, activation of the UPR and inhibition of the sirtuin signaling pathway were noted in C when compared to R. The most striking difference in liver transcriptomic response between C and B was the activation of the acute phase response and inhibition of bile acid synthesis in the latest group. Our results suggest that excessive consumption of animal fats leads to the activation of a cascade of mutually propelling processes harmful to the liver: inflammation, UPR, and imbalances in the biosynthesis of cholesterol and bile acids via altered organelle membrane composition. Nevertheless, these studies should be extended with analysis at the level of proteins and their function.Entities:
Keywords: 3′quant mRNA-seq; fatty acids; nutrigenomics; pigs
Mesh:
Substances:
Year: 2020 PMID: 32961898 PMCID: PMC7565913 DOI: 10.3390/genes11091087
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Percentage of the most abundant fatty acids in the diets.
RNA-seq statistics of Quant-seq 3′mRNA-sequencing.
| Sample Name | No of Raw Reads | No of Mapped Reads | Percentage of Mapped Reads (%) |
|---|---|---|---|
| 17w | 3,355,869 | 2,635,495 | 78.5 |
| 19w | 2,460,130 | 1,927,026 | 78.3 |
| 20w | 2,029,705 | 1,615,350 | 79.6 |
| 21w | 2,819,316 | 2,187,454 | 77.6 |
| 22w | 2,657,611 | 2,111,384 | 79.4 |
| 24w | 2,298,911 | 1,803,582 | 78.5 |
| 41w | 3,469,934 | 2,760,471 | 79.6 |
| 42w | 2,223,698 | 1,817,882 | 81.8 |
| 43w | 4,124,251 | 3,197,675 | 77.5 |
| 45w | 2,157,086 | 1,710,536 | 79.3 |
| 46w | 2,415,641 | 1,932,621 | 80.0 |
| 48w | 2,470,229 | 1,981,470 | 80.2 |
| 49w | 2,715,605 | 2,203,190 | 81.1 |
| 52w | 2,631,687 | 2,119,487 | 80.5 |
| 53w | 2,110,920 | 1,648,309 | 78.1 |
| 54w | 2,031,614 | 1,625,581 | 80.0 |
| 55w | 4,000,000 | 3,266,253 | 81.7 |
| 56w | 4,000,000 | 3,262,080 | 81.6 |
Top 20 DEGs with the highest adjusted p-value for each comparison.
| Ensembl ID | Base | log2 Fold | Gene Description | Gene Symbol | |
|---|---|---|---|---|---|
|
| |||||
| ENSSSCG00000021443 | 109 | −1.46 | 0.0005 | serum/glucocorticoid regulated kinase 1 |
|
| ENSSSCG00000032381 | 221 | −1.42 | 0.0000 | lipopolysaccharide induced TNF factor |
|
| ENSSSCG00000004700 | 288 | −1.34 | 0.0007 | protein disulfide isomerase family A member 3 |
|
| ENSSSCG00000028758 | 177 | −1.28 | 0.0000 | lipopolysaccharide binding protein |
|
| ENSSSCG00000000892 | 127 | −1.23 | 0.0008 | histidine ammonia-lyase |
|
| ENSSSCG00000033214 | 460 | −1.16 | 0.0098 | glycine N-methyltransferase |
|
| ENSSSCG00000016174 | 361 | −1.16 | 0.0185 | fibronectin 1 |
|
| ENSSSCG00000008998 | 23136 | −1.01 | 0.0001 | fibrinogen α chain |
|
| ENSSSCG00000013514 | 256 | −0.94 | 0.0001 | LRRCT domain-containing protein |
|
| ENSSSCG00000008550 | 317 | −0.86 | 0.0124 | solute carrier family 5 member 6 |
|
| ENSSSCG00000022126 | 122 | −0.79 | 0.0025 | epidermal growth factor receptor |
|
| ENSSSCG00000002487 | 1830 | −0.78 | 0.0027 | α-1-antichymotrypsin 2 |
|
| ENSSSCG00000002749 | 37957 | −0.59 | 0.0162 | haptoglobin |
|
| ENSSSCG00000011453 | 1755 | −1.43 | 0.0000 | inter-α-trypsin inhibitor heavy chain 4 |
|
| ENSSSCG00000011741 | 340 | 0.45 | 0.0185 | golgi integral membrane protein 4 |
|
| ENSSSCG00000027072 | 172 | 0.56 | 0.0112 | ATP synthase inhibitory factor subunit 1 |
|
| ENSSSCG00000002529 | 355 | 0.65 | 0.0036 | 40S ribosomal protein S21 |
|
| ENSSSCG00000008829 | 182 | 0.80 | 0.0076 | OCIA domain containing 2 |
|
| ENSSSCG00000026044 | 221 | 1.34 | 0.0005 | farnesyl-diphosphate farnesyltransferase 1 |
|
| ENSSSCG00000006238 | 84 | 2.11 | 0.0007 | cytochrome P450 family 7 subfamily A member 1 |
|
|
| |||||
| ENSSSCG00000006238 | 100 | −2.63 | 4 × 10-8 | cytochrome P450 family 7 subfamily A member 1 |
|
| ENSSSCG00000028821 | 27 | −2.14 | 1.6 × 105 | SAS-6 centriolar assembly protein |
|
| ENSSSCG00000004586 | 19 | −2.02 | 6.5 × 105 | family with sequence similarity 81 member A |
|
| ENSSSCG00000033822 | 110 | −1.91 | 6.6 × 105 | thyroid hormone responsive |
|
| ENSSSCG00000026044 | 252 | −1.80 | 1.6 × 105 | farnesyl-diphosphate farnesyltransferase 1 |
|
| ENSSSCG00000006719 | 94 | −1.41 | 1.6 × 107 | hydroxy-delta-5-steroid dehydrogenase, 3 β- and steroid delta-isomerase 1 |
|
| ENSSSCG00000006040 | 186 | −1.20 | 2.6 × 106 | dihydropyrimidinase |
|
| ENSSSCG00000001849 | 153 | −0.89 | 1.7 × 104 | alanyl aminopeptidase, membrane |
|
| ENSSSCG00000039388 | 448 | −0.84 | 8.3 × 105 | ||
| ENSSSCG00000023686 | 5283 | −0.78 | 3.4 × 104 | transthyretin |
|
| ENSSSCG00000015106 | 124 | 1.23 | 1.5 × 104 | hypoxia up-regulated 1 |
|
| ENSSSCG00000032381 | 218 | 1.35 | 3.4 × 104 | lipopolysaccharide induced TNF factor |
|
| ENSSSCG00000011297 | 222 | 1.36 | 6.6 × 105 | abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
|
| ENSSSCG00000015140 | 293 | 1.38 | 8.7 × 109 | heat shock protein family A (Hsp70) member 8 |
|
| ENSSSCG00000030095 | 78 | 1.49 | 2.4 × 104 | zinc finger and BTB domain containing 16 |
|
| ENSSSCG00000020754 | 32 | 1.51 | 6.5 × 105 | RNA polymerase I subunit G |
|
| ENSSSCG00000005601 | 1136 | 1.54 | 1.8 × 1013 | heat shock protein family A (Hsp70) member 5 |
|
| ENSSSCG00000022126 | 97 | 1.73 | 4.0 × 1013 | epidermal growth factor receptor |
|
| ENSSSCG00000010686 | 369 | 1.79 | 8.3 × 106 | BAG cochaperone 3 |
|
| ENSSSCG00000035058 | 43 | 1.82 | 6.3 × 106 | phosphotyrosine interaction domain containing 1 |
|
|
| |||||
| ENSSSCG00000023331 | 67 | −1.35 | 0.0000 | ubiquitin like 5 |
|
| ENSSSCG00000007710 | 75 | −1.14 | 0.0033 | MLX interacting protein lik |
|
| ENSSSCG00000027926 | 94 | −1.14 | 0.0062 | formimidoyltransferase cyclodeaminase |
|
| ENSSSCG00000003302 | 193 | −1.01 | 0.0004 | Lysoplasmalogenase |
|
| ENSSSCG00000031881 | 48 | −1.01 | 0.0003 | CDC42 small effector 1 |
|
| ENSSSCG00000035790 | 110 | −0.93 | 0.0048 | BTG anti-proliferation factor 1 |
|
| ENSSSCG00000006719 | 105 | −0.92 | 0.0013 | hydroxy-delta-5-steroid dehydrogenase, 3 β- and steroid delta-isomerase 1 |
|
| ENSSSCG00000031302 | 46 | −0.91 | 0.0015 | C-terminal binding protein 1 |
|
| ENSSSCG00000010627 | 45 | −0.88 | 0.0064 | programmed cell death 4 |
|
| ENSSSCG00000013514 | 225 | −0.73 | 0.0064 | LRRCT domain-containing protein |
|
| ENSSSCG00000001849 | 163 | −0.65 | 0.0062 | alanyl aminopeptidase, membrane |
|
| ENSSSCG00000014855 | 870 | −0.62 | 0.0002 | ribosomal protein S3 |
|
| ENSSSCG00000011000 | 253 | 0.86 | 0.0013 | ||
| ENSSSCG00000022126 | 69 | 0.94 | 0.0007 | epidermal growth factor receptor |
|
| ENSSSCG00000039147 | 108 | 0.96 | 0.0014 | ||
| ENSSSCG00000015140 | 278 | 1.14 | 0.0000 | heat shock protein family A (Hsp70) member 8 |
|
| ENSSSCG00000004093 | 290 | 1.14 | 0.0000 | iodotyrosine deiodinase |
|
| ENSSSCG00000010686 | 339 | 1.49 | 0.0000 | BAG cochaperone 3 |
|
| ENSSSCG00000011437 | 132 | 1.50 | 0.0005 | 5′-aminolevulinate synthase 1 |
|
| ENSSSCG00000024596 | 69 | 1.62 | 0.0051 | nocturnin |
|
Bold genes were annotated with the Uniprot database.
Figure 2Venn diagram illustrating differentially expressed genes that are common between comparisons.
Figure 3The network of DEGs downregulated in the beef tallow group when compared to the rapeseed oil group according to STRING software analysis.
Figure 4The network of DEGs upregulated in the beef tallow group when compared to the rapeseed oil group according to STRING software analysis.
Figure 5Canonical pathways with Z score ≠ 0 and log (p-value) > 1.3, identified in each comparison using IPA software.
Figure 6Top 10 Hub genes identified in the R vs. B comparison, R vs. C comparison, and B vs. C comparison using Cytohubba, ranked by MCC (Maximal Clique Centrality). The more intense the red color, the higher the position in the rank.
Figure 7Results of the qPCR analysis of selected DEGs. RQ—Relative Quantity of mRNA, *** p < 0.01, ** p < 0.05, * p < 0.1, ns—not significant.
Figure 8Graphical illustration of selected biological processes and canonical pathways altered in the beef tallow group when compared to rapeseed oil. Beef tallow contains pro-inflammatory ingredients (SFA, AA—arachidonic acid) that could change gut microbiota and promote inflammation. SFA and cholesterol from beef tallow decrease cholesterol biosynthesis directly in the liver and indirectly through inhibition of LXR/RXR by LPS/IL-1.
Figure 9Graphical illustration of selected biological processes and canonical pathways altered in the coconut oil group when compared to the rapeseed oil (UPR, sirtuin signaling pathway) and beef tallow groups (LXR/RXR activation, cholesterol metabolism, bile secretion). Coconut oil contains antibacterial and anti-inflammatory ingredients (lauric acids, polyphenols), and cholesterol metabolism and bile acid secretion are not reduced as a result of increased inflammation, which is observed in the beef tallow group.